ID ...... Создание производства инфузионных растворов и парентерального питания

• Дата добавления

  09.11.2020

• Последнее обновление

  01.03.2022

• Стадия

  

  Введен в эксплуатацию

• Тип работ

  Новое строительство

• Местоположение

  ·············· ······ ···· ·············· ·············· ·········· ·············· ······ ················ ············ ·········· ················ ·············· ········ ········ ···· ······

• Производственная площадка

  ···· ········ ···· ················ ····
  

  Объем инвестиций активных проектов: ············ ·········· руб.

  
  Топ-5 активных проектов площадки
  

  1. ID 53907 Строительство логистического центра (Приостановлен на стадии «Проектирование» в 2025 году) (Калужская область, Ворсино) — 17,6 млрд руб

  2. ID 63474 Строительство фармацевтического завода (Приостановлен на стадии «Подготовка к строительству» в 2024 году) (Калужская область, Ворсино) — 9 млрд руб

  3. ID 75915 Строительство логистического комплекса (2-ой этап) (Приостановлен на стадии «Подготовка к строительству» в 2022 году) (Калужская область, Ворсино) — 1,8 млрд руб

  4. ID 1734 Создание мультимодального логистического комплекса (3-я очередь) (Подготовка к строительству) (Калужская область, Ворсино) — 700 млн руб

  5. ID 194690 Реконструкция автомобильной дороги 1 этап (Строительство) (Калужская область, Ворсино) — 473 млн руб

• Краткое описание

  В Центральном ФО инвестор вложит ₽500 млн в создание производства по выпуску инфузионных растворов и парентерального питания. Производственные мощности планируют запустить в полном объеме в 2021 году.

• Полное описание

  ········ ·············· ······ ···· ········ ·········· ···· ········ ················ ···· ·········· ················ ······ ········ ········ ················ ·············· ·········· ·········· ·············· ················ ······ ······ ······ ···· ···· ······ ········ ············ ·········· ········ ········ ········ ·············· ········ ········ ·········· ················ ······ ·············· ······ ········ ················ ·············· ················ ·········· ·············· ·············· ············ ······ ············ ············ ······ ······ ······ ·········· ······ ········ ···· ······ ············ ·············· ······ ···· ·············· ········ ············ ·············· ············ ······ ················ ·········· ···· ·········· ············ ······ ················ ············ ········ ············ ·········· ···· ······ ········ ············ ·········· ················ ···· ········ ········ ···· ················ ·············· ·········· ·········· ············ ········ ···· ············ ········ ·········· ·········· ········ ·············· ················ ········ ················ ···· ············ ···· ············ ······ ············ ············ ······ ·········· ·········· ·········· ···· ·············· ················ ·········· ·········· ·············· ················ ······ ···· ············ ··········

• Результаты интервью

  ···· ·················· ···· ····.····.········ ············ ·················· ···· ·················· ·············· ········ ·················· ·· ·························· ·································· ··························

• Объем инвестиций

  ············ ··········

• Сроки проекта

  2020 — 2021

• Вид собственности

  Частный

• Отрасль

  Фармацевтическая промышленность

• Подотрасль

  Лекарственные препараты

• Производственная мощность

  ········ ·············· ············ ················ ········ ············ ·············· ·············· ············ ···· ········ ················ ·············· ················ ········ ······ ······ ················

• Готовая продукция

  ·············· ·············· ···· ········ ···· ·········· ················ ············ ·············· ····